MUMBAI —
India's government announced details of a policy aimed to make drugs more affordable, measures that may cut profitability of drugmakers such as GlaxoSmithKline.
Prices of 348 medicines deemed essential, including antibiotics, blood pressure drugs, and cancer medicines will be capped at the average price of all brands that have a market share exceeding 1 percent, the department of pharmaceuticals said in a document posted on its website. The Supreme Court is expected to discuss the policy in a hearing Wednesday.
GlaxoSmithKline, Pfizer and Abbott Laboratories may be the biggest losers from the price cap as their products are the most expensive, according to a Nov. 22 report by IMS Health Inc. The price caps will probably lower prices as about 90 percent of all prescriptions in India are generics or branded generics, which their manufacturers often seek to differentiate with unique names.
"There will be a short-term impact on drugmakers whose products have commanded premium prices," Hitesh Mahida, an analyst at Fortune Equity Brokers, said by phone. "However, companies are likely to increase prices of other products or introduce new combinations and dosages of drugs that are not under price control."
The policy would shrink the size of India's pharmaceutical market by about 2 percent, according to the IMS report. After implementation, about 30 percent of the nation's drug market would be under price control, the report said.
India's 17-year-old drug price control regime allows drugmakers to charge a predefined margin above their manufacturing cost. The government chose to switch to a so- called "market-based" price cap system, as it was difficult to get accurate data on manufacturing costs from hundreds of drugmakers, according to the government.
"Market based pricing is directionally prudent for India in the longterm," even though drugmakers are likely to lose some revenue in the coming months, Tapan Ray, director general of the Organisation of Pharmaceutical Producers of India, said by e-mail. "It is expected to help improving both affordability and availability of the medicines."
When prescribing medication, Indian doctors typically refer to brands rather than chemical names. Pharmacists are prohibited from substituting one generic for another, even if it's cheaper, so drugmakers try to persuade physicians to think of their brands first.
The announcement comes about three months after a group of ministers approved the pricing plan in time to meet a deadline set by the Supreme Court. The nation's top court weighed into the issue following a petition filed by four patients rights groups including the All India Drug Action Network, which said the government was delaying legislation to make medicines more affordable.
The two-judge panel hearing the case questioned the new price cap formula, and asked the government to instead continue the existing system which based on manufacturing costs, the Economic Times reported Oct. 5.
The list used by the government specifies the exact dosages for each drug, and drugmakers are likely to introduce other dosages to evade price control, Mira Shiva, founder of the New Delhi-based All India Drug Action Network said Tuesday.
"More than 80 percent of the country's population pay for medicines out-of-pocket, and they will not benefit because of this," Shiva said in a phone interview. Price caps "have to have some link to what it costs to produce the drugs."
The notification doesn't place price caps on patented drugs, and grants five-year exemptions to medicines that were produced with research done in the country.
Business
India to introduce limits on drugs to rein in health care costs
- Business
-
-
Hibbett posts flat 1Q net income
Hibbett Sports Inc. on Friday posted relatively flat net income for its fiscal first quarter, as colder-than-normal weather reduced demand for some of its spring merchandise.
-
Business licenses for April 2013
The following is a list of business licenses applied for in the Cullman County area:
-
Restaurant learns online reviews can make or break
It was the customer service disaster heard around the Internet.
-
Nicholson/Papapietro named to 2013 Best Doctors in America list
Cullman Regional Medical Center’s Chairman of Radiology, Jeffrey K. Nicholson, MD has been named one of the Best Doctors in America for 2013. The prestigious recognition marks the second time that Dr. Nicholson has earned this honor.
Cullman Regional Medical Center’s Interventional Cardiologist, Silvio Papapietro has also been named one of the Best Doctors in America for 2013. This marks the seventh time that “Dr. Papa,” as most of his patients know him, has earned this honor.
-
Panel: Apple uses firms outside US to avoid taxes
Apple Inc. employs a group of affiliate companies located outside the United States to avoid paying billions of dollars in U.S. income taxes, a Senate investigation has found.
-
VIDEO: Tumblr sold to Yahoo! for $1.1 billion
Yahoo! has purchased Tumblr for $1.1 billion, hoping to compete more effectively with sites like Google and Facebook.
-
How to get the most out of your air conditioner this summer
Experts say preventative maintenance on your air conditioner can save you hundreds of dollars.
-
VIDEO: Man hands out Abercrombie clothes on Skid Row in bid to shame brand
Anger has mounted online against clothing retailer Abercrombie & Fitch due to comments made by its chief executive and its strategy of not making women's clothing in any size above large.
-
VIDEO: How robots will shape the future
Robots could revolutionize everything from learning to fitness. Tech reporter Rich DeMuro shows how companies are using robots to shape the future.
-
Slate to Lady Interns: Leave the Thongs at Home
It's that time of year, folks. Winter coats are being stored away, blossoms are dappling the trees, and before long, the annual summer parade of skinterns will begin.
- More Business Headlines
-
Hibbett posts flat 1Q net income



